Topol on Cancer 'Cures': Are We Being Misled?

|Disclosures|June 17, 2014
 

Dear Medscape Readers,

I'd like to review with you 2 areas of medicine that have been receiving noteworthy attention in recent weeks.

Three Rapid-Fire Announcements

Digital health took center stage with 3 rapid-fire announcements by Samsung, Apple, and Google -- all within 2 weeks -- of their new platforms that track health and medical data. Whether the data are displayed on a smartphone screen or watch, the commitment of some of the world's top technology companies to aggregate data on activity, heart rate, blood pressure, glucose, and an expanding list of physiologic metrics is noteworthy.

It further represents the convergence of the tech and medical sectors. This "managed competition" should accelerate the era of patient-generated data. Furthermore, beyond aggregating data, these companies are developing sensors and hardware to provide innovative means of tracking medically relevant information. A big challenge for the tech companies is to make this practical, interoperable, and user-friendly for physicians and health systems. Reciprocally, it will be interesting to see how physicians and health systems adapt to this new workflow and torrent of data coming from patients.

Which brings me to another point about adapting to the changes induced by medicine going digital. I prepared the graph below to show where we stand, adapting a general industry graph template by McKinsey.[1] It's still early in a major disruptive time in medicine, where incumbents will be further challenged. As you well know, there is major consolidation in health systems to adapt to the marked reduction in reimbursement accompanying the Affordable Care Act. Many innovative startups have come on the scene, running the gamut from sensors to telemedicine. There have been several early adopters of digital technology, such as Intermountain, Kaiser Permanente, and medical practices like One Medical. And some of the incumbents, like Mayo Clinic, are starting to adapt, evidenced by their partnership with Apple on the HealthKit tracking platform. But there's plenty more change and disruption ahead. An alternative view, as articulated in the recent New Yorker piece by Jill Lepore,[2] challenges whether there really is disruptive innovation at all!

Two more quick points: If you haven't seen it, check out the new Medscape pill identifier, which can really come in handy when a patient doesn't know what medication or dose he or she is taking -- a common situation. And I would like to congratulate Medscape, which won a GOLD award in the 2014 Winter/Spring Web Health Awards competition for its Medscape Today page.

 
1 of 2
 
 
Latest in Hematology-Oncology

References

  1. McKinsey & Company. Strategic principles for competing in the digital age. http://www.mckinsey.com/insights/strategy/strategic_principles_for_competing_in_the_digital_age Accessed June 16, 2014.

  2. Lepore J. The disruption machine: what the gospel of innovation gets wrong. New Yorker. June 23, 2014. http://www.newyorker.com/reporting/2014/06/23/140623fa_fact_lepore Accessed June 17, 2014.

  3. Vater LB, Donohue JM, Arnold R, et al. What are cancer centers advertising to the public?: A content analysis. Ann Intern Med. 2014 May 27. [Epub ahead of print]

Authors and Disclosures

Author

Eric J. Topol, MD

Director, Scripps Translational Science Institute; Chief Academic Officer, Scripps Health; Professor of Genomics, The Scripps Research Institute, La Jolla, California; Editor-in-Chief, Medscape

Disclosure: Eric J. Topol, MD, has disclosed the following relevant financial relationships:
Serve(d) as a director, officer, partner, employee, advisor, consultant, or trustee for: AltheaDX; AT&T; Biological Dynamics; Cypher Genomics (Co-founder); Dexcom; GenapSys; Gilead Sciences, Inc.; Illumina, Inc.; Portola Pharmaceuticals; Quest Diagnostics; Sotera Wireless; Volcano; Walgreen Company
Received research grant from: National Institutes of Health; Qualcomm Foundation

Comments on Medscape are moderated and should be professional in tone and on topic. You must declare any conflicts of interest related to your comments and responses. Please see our Commenting Guide for further information. We reserve the right to remove posts at our sole discretion.
Post as:

processing....

All material on this website is protected by copyright, Copyright © 1994-2016 by WebMD LLC. This website also contains material copyrighted by 3rd parties.